Impact of Dietary Fibre Supplementation on Gut Symptoms in Healthy Participants

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity of Helsinki

About this trial

Fibres found in food are mainly carbohydrates that are not broken down or absorbed during human digestion but instead pass to the colon to be fermented by microbes. Gases produced during bacterial fermentation (hydrogen, methane, and carbon dioxide), can cause unpleasant gastrointestinal symptoms in some individuals, such as bloating, flatulence, and stomach pain. Gas production varies between individuals and is influenced by the chemical structure of dietary fibres, the gut microbes' ability to ferment fibre, intestinal pH, and the transit time of intestinal contents. This randomized clinical trial in healthy adults will investigate how individual variations in the microbiome influence the level of gastrointestinal (GI) symptoms induced by different fibre types during short-term exposure.

Eligibility criteria

Qualifiers

healthy male and female

aged 18-65 years

experience gastrointestinal discomfort during or after eating

willing to commit to the 6-week study period and follow the study schedule.

Disqualifiers

Body mass index ≤ 18.5 or ≥ 35 kg/m².

Inflammatory bowel diseases, irritable bowel syndrome (IBS), celiac disease, endocrine or lipid metabolism disorders, liver or kidney diseases, cancer within the past 5 years, eating disorders.

Medication for gastrointestinal symptoms, bowel function, diabetes, or hypercholesterolemia.

Regular or recent use of antibiotics (within the last 3 months).

Trial design

Treatments tested in this trial

  • cellulose
  • Oat fibre
  • Rye fibre

Treatment groups

28 Participants
are divided into 3 treatment groups

Sponsors and collaborators